AstraZeneca

AstraZeneca has been generous in its support of BACR activities for many years. This includes the BACR/AstraZeneca Young Scientist Frank Rose Award, first given in 1993 to reward the achievement of a young scientist who had made a significant contribution to cancer research.

In recent years, the Award has been presented at the annual National Cancer Research Institute cancer conference. AstraZeneca continues to support this Award and selected BACR meetings of specific interest. The BACR wishes to express its gratitude to AstraZeneca for its continuing support.

About AstraZeneca

AstraZeneca is one of the world's leading pharmaceutical companies, with a broad range of medicines designed to fight disease in important areas of healthcare: gastrointestinal, cardiovascular, neuroscience, respiratory, cancer and infection. Backed by strong science and wide-ranging commercial skills, AstraZeneca is committed to the sustainable development of its business and the delivery of a flow of new medicines that bring benefit for patients and add value for wider society.

For more information about AstraZeneca, please visit http://www.astrazeneca.co.uk/home